APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ipilimumab Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ipilimumab Injection Industry Growth and Trends Forecast to 2032

27 December 202576 pages

Choose your research edition.

Industry ResearchIpilimumab Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Ipilimumab Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Ipilimumab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ipilimumab Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Ipilimumab Injection Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Ipilimumab Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ipilimumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ipilimumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ipilimumab Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ipilimumab Injection include Bristol Myers Squibb. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ipilimumab Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ipilimumab Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ipilimumab Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ipilimumab Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ipilimumab Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ipilimumab Injection Market by Company

Bristol Myers Squibb

Ipilimumab Injection Segment by Type

50mg per Vial

200mg per Vial

Ipilimumab Injection Segment by Application

Malignant Thymic Mesothelioma

Non-small Cell Lung Cancer

Hepatocellular Carcinoma

Melanoma

Colorectal Cancer

Renal Cell Carcinoma

Other

Ipilimumab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ipilimumab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ipilimumab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ipilimumab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ipilimumab Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ipilimumab Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg per Vial Table 2. Major Company of 200mg per Vial Table 3. Global Ipilimumab Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Ipilimumab Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ipilimumab Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Ipilimumab Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ipilimumab Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Ipilimumab Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ipilimumab Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ipilimumab Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Ipilimumab Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ipilimumab Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ipilimumab Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Ipilimumab Injection Industry Trends Table 25. Ipilimumab Injection Industry Drivers Table 26. Ipilimumab Injection Industry Opportunities and Challenges Table 27. Ipilimumab Injection Industry Restraints Table 28. Global Ipilimumab Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ipilimumab Injection Revenue Market Share by Company (2021-2026) Table 30. Global Ipilimumab Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Ipilimumab Injection Sales Share by Company (2021-2026) Table 32. Global Ipilimumab Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ipilimumab Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ipilimumab Injection Major Company Production Sites and Headquarters Table 35. Global Ipilimumab Injection Company, Product Type & Application Table 36. Global Ipilimumab Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ipilimumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ipilimumab Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ipilimumab Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Ipilimumab Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ipilimumab Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ipilimumab Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Ipilimumab Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ipilimumab Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Ipilimumab Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ipilimumab Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ipilimumab Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Ipilimumab Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ipilimumab Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Ipilimumab Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ipilimumab Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Ipilimumab Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ipilimumab Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Ipilimumab Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ipilimumab Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ipilimumab Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Ipilimumab Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ipilimumab Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ipilimumab Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Bristol Myers Squibb Company Information Table 72. Bristol Myers Squibb Business Overview Table 73. Bristol Myers Squibb Ipilimumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol Myers Squibb Ipilimumab Injection Product Portfolio Table 75. Bristol Myers Squibb Recent Development Table 76. North America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 77. North America Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 78. North America Ipilimumab Injection Sales Market Share by Country (2021-2026) Table 79. North America Ipilimumab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 80. North America Ipilimumab Injection Sales Market Share Forecast by Country (2027-2032) Table 81. North America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Ipilimumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Ipilimumab Injection Market Share by Country (2021-2026) Table 84. North America Ipilimumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Ipilimumab Injection Market Share Forecast by Country (2027-2032) Table 86. Europe Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. Europe Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 88. Europe Ipilimumab Injection Sales Market Share by Country (2021-2026) Table 89. Europe Ipilimumab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 90. Europe Ipilimumab Injection Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Ipilimumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Ipilimumab Injection Market Share by Country (2021-2026) Table 94. Europe Ipilimumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Ipilimumab Injection Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 98. Asia-Pacific Ipilimumab Injection Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Ipilimumab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 100. Asia-Pacific Ipilimumab Injection Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Ipilimumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Ipilimumab Injection Market Share by Country (2021-2026) Table 104. Asia-Pacific Ipilimumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Ipilimumab Injection Market Share Forecast by Country (2027-2032) Table 106. Latin America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Latin America Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 108. Latin America Ipilimumab Injection Sales Market Share by Country (2021-2026) Table 109. Latin America Ipilimumab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 110. Latin America Ipilimumab Injection Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Ipilimumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Ipilimumab Injection Market Share by Country (2021-2026) Table 114. Latin America Ipilimumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Ipilimumab Injection Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Ipilimumab Injection Sales by Country (2021-2026) & (K Units) Table 118. Middle East and Africa Ipilimumab Injection Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Ipilimumab Injection Sales Forecast by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Ipilimumab Injection Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Ipilimumab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Ipilimumab Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Ipilimumab Injection Market Share by Country (2021-2026) Table 124. Middle East and Africa Ipilimumab Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Ipilimumab Injection Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Ipilimumab Injection Distributors List Table 129. Ipilimumab Injection Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Ipilimumab Injection Image Figure 2. Global Ipilimumab Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ipilimumab Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Ipilimumab Injection Sales (2021-2032) & (K Units) Figure 5. 50mg per Vial Image Figure 6. Global 50mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 7. 200mg per Vial Image Figure 8. Global 200mg per Vial Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ipilimumab Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ipilimumab Injection Market Share by Type 2025 VS 2032 Figure 11. North America Ipilimumab Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Ipilimumab Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Ipilimumab Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ipilimumab Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ipilimumab Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ipilimumab Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ipilimumab Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ipilimumab Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ipilimumab Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ipilimumab Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ipilimumab Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Malignant Thymic Mesothelioma Image Figure 24. Global Malignant Thymic Mesothelioma Sales YoY Growth (2021-2032) & (K Units) Figure 25. Non-small Cell Lung Cancer Image Figure 26. Global Non-small Cell Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hepatocellular Carcinoma Image Figure 28. Global Hepatocellular Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Melanoma Image Figure 30. Global Melanoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Colorectal Cancer Image Figure 32. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Renal Cell Carcinoma Image Figure 34. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Ipilimumab Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Ipilimumab Injection Market Share by Application 2025 VS 2032 Figure 39. North America Ipilimumab Injection Sales Market Share in Volume by Application in 2025 Figure 40. North America Ipilimumab Injection Sales Market Share in Value by Application in 2025 Figure 41. Europe Ipilimumab Injection Sales Market Share in Volume by Application in 2025 Figure 42. Europe Ipilimumab Injection Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Ipilimumab Injection Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Ipilimumab Injection Sales Market Share in Value by Application in 2025 Figure 45. Latin America Ipilimumab Injection Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Ipilimumab Injection Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Ipilimumab Injection Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Ipilimumab Injection Sales Market Share in Value by Application in 2025 Figure 49. North America Ipilimumab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Ipilimumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Ipilimumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Ipilimumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ipilimumab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Ipilimumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Ipilimumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Ipilimumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ipilimumab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Ipilimumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Ipilimumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Ipilimumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ipilimumab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Ipilimumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Ipilimumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Ipilimumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ipilimumab Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Ipilimumab Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Ipilimumab Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Ipilimumab Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Ipilimumab Injection Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Ipilimumab Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg per Vial
  • 200mg per Vial
Applications
  • Malignant Thymic Mesothelioma
  • Non-small Cell Lung Cancer
  • Hepatocellular Carcinoma
  • Melanoma
  • Colorectal Cancer
  • Renal Cell Carcinoma
  • Other
Companies covered
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ipilimumab Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ipilimumab Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ipilimumab Injection Market by Type
  6. 1.3.1 50mg per Vial
  7. 1.3.2 200mg per Vial
  8. 1.4 Global Ipilimumab Injection Market Size by Type
  9. 1.4.1 Global Ipilimumab Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ipilimumab Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ipilimumab Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ipilimumab Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ipilimumab Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ipilimumab Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ipilimumab Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ipilimumab Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ipilimumab Injection Industry Trends
  2. 2.2 Ipilimumab Injection Industry Drivers
  3. 2.3 Ipilimumab Injection Industry Opportunities and Challenges
  4. 2.4 Ipilimumab Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ipilimumab Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Ipilimumab Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Ipilimumab Injection Price (2021-2026)
  4. 3.4 Global Ipilimumab Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ipilimumab Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Ipilimumab Injection Company, Product Type & Application
  7. 3.7 Global Ipilimumab Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ipilimumab Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ipilimumab Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ipilimumab Injection Tier 1, Tier 2, and Tier 3
4 Ipilimumab Injection Regional Status and Outlook
  1. 4.1 Global Ipilimumab Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ipilimumab Injection Historic Market Size by Region
  3. 4.2.1 Global Ipilimumab Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ipilimumab Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ipilimumab Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ipilimumab Injection Forecasted Market Size by Region
  7. 4.3.1 Global Ipilimumab Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ipilimumab Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ipilimumab Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ipilimumab Injection by Application
  1. 5.1 Ipilimumab Injection Market by Application
  2. 5.1.1 Malignant Thymic Mesothelioma
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.1.3 Hepatocellular Carcinoma
  5. 5.1.4 Melanoma
  6. 5.1.5 Colorectal Cancer
  7. 5.1.6 Renal Cell Carcinoma
  8. 5.1.7 Other
  9. 5.2 Global Ipilimumab Injection Market Size by Application
  10. 5.2.1 Global Ipilimumab Injection Market Size Overview by Application (2021-2032)
  11. 5.2.2 Global Ipilimumab Injection Historic Market Size Review by Application (2021-2026)
  12. 5.2.3 Global Ipilimumab Injection Forecasted Market Size by Application (2027-2032)
  13. 5.3 Key Regions Market Size by Application
  14. 5.3.1 North America Ipilimumab Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.2 Europe Ipilimumab Injection Sales Breakdown by Application (2021-2026)
  16. 5.3.3 Asia-Pacific Ipilimumab Injection Sales Breakdown by Application (2021-2026)
  17. 5.3.4 South America Ipilimumab Injection Sales Breakdown by Application (2021-2026)
  18. 5.3.5 Middle East and Africa Ipilimumab Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol Myers Squibb
  2. 6.1.1 Bristol Myers Squibb Company Information
  3. 6.1.2 Bristol Myers Squibb Business Overview
  4. 6.1.3 Bristol Myers Squibb Ipilimumab Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol Myers Squibb Ipilimumab Injection Product Portfolio
  6. 6.1.5 Bristol Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America Ipilimumab Injection Sales by Country
  2. 7.1.1 North America Ipilimumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ipilimumab Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Ipilimumab Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ipilimumab Injection Market Size by Country
  6. 7.2.1 North America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ipilimumab Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Ipilimumab Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ipilimumab Injection Sales by Country
  2. 8.1.1 Europe Ipilimumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ipilimumab Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Ipilimumab Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ipilimumab Injection Market Size by Country
  6. 8.2.1 Europe Ipilimumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ipilimumab Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ipilimumab Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ipilimumab Injection Sales by Country
  2. 9.1.1 Asia-Pacific Ipilimumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ipilimumab Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ipilimumab Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ipilimumab Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Ipilimumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ipilimumab Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ipilimumab Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ipilimumab Injection Sales by Country
  2. 10.1.1 South America Ipilimumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ipilimumab Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Ipilimumab Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ipilimumab Injection Market Size by Country
  6. 10.2.1 South America Ipilimumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ipilimumab Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Ipilimumab Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ipilimumab Injection Sales by Country
  2. 11.1.1 Middle East and Africa Ipilimumab Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ipilimumab Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ipilimumab Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ipilimumab Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Ipilimumab Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ipilimumab Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ipilimumab Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ipilimumab Injection Value Chain Analysis
  2. 12.1.1 Ipilimumab Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ipilimumab Injection Production Mode & Process
  7. 12.2 Ipilimumab Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ipilimumab Injection Distributors
  10. 12.2.3 Ipilimumab Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst